Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Elife|April 26, 2022
Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferationClaudio Tripodo, Barbara Bassani, Elena Jachetti, et al.
Virchows Archiv : an International Journal of Pathology|April 22, 2016
In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+ and HER2 2+/Her2 amplified casesSilvia Giuliani, Chiara Maura Ciniselli, Elena Leonardi, et al.
Oncotarget|May 21, 2017
Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spreadFilippo Spreafico, Italia Bongarzone, Sara Pizzamiglio, et al.
Alternatives to Laboratory Animals : ATLA|May 29, 2010
Prevalidation of the rat CFU-GM assay for in vitro toxicology applicationsAugusto Pessina, Arianna Bonomi, Loredana Cavicchini, et al.
Molecular Oncology|June 20, 2017
β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expressionChiara Colombo, Antonino Belfiore, Nicholas Paielli, et al.
La Radiologia Medica|April 20, 2018
Different pixel pitch and maximum luminance of medical grade displays may result in different evaluations of digital radiography imagesAlberto Laffranchi, Calogero Cicero, Manuela Lualdi, et al.
JCO Precision Oncology|September 26, 2025
Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian CancerChiara Maura Ciniselli, Elena Conca, Michele Bartoletti, et al.
Cancers|June 2, 2021
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical VariablesPaolo Gandellini, Chiara Maura Ciniselli, Tiziana Rancati, et al.
Oncotarget|July 2, 2014
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signalsLaura Gatti, Alexandra Sevko, Michelandrea De Cesare, et al.
Cancer Gene Therapy|March 30, 2022
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesotheliomaRihan El Bezawy, Stefano Percio, Chiara Maura Ciniselli, et al.
Pageof 16